Introduction
Intracerebral hemorrhage (ICH), which accounts for ~15%-20% of all deaths from stroke, is one of the most devastating stroke subtypes; it has a grave prognosis and is characterized by the rupturing of small blood vessels in the brain parenchyma (Donnan et al., 2008 , Qureshi et al., 2009 .
Development of novel treatment strategies based on the distinct pathogenic mechanisms of ICH is warranted to achieve improved clinical results.
MicroRNA (miRNA) is a short sequence noncoding RNA with 22 base pairs that regulates gene expression in the post-transcription step by base-pairing with the target messenger RNA of the 3′ untranslated region (Kim et al., 2009) , playing significant roles in multiple physiological and pathological processes (Kloosterman and Plasterk, 2006; Stefani and Slack, 2008) . Its expression level is dynamic in human developmental stages and in diseases, and several studies have confirmed the therapeutic potential of modulating miRNA expression (Kim et al., 2009; Lee et al., 2010; Jimenez-Mateos et al., 2012) . miR-34 was first found in Caenorhabditis elegans in 2001 (Lau et al., 2001) . Two subtypes, miR-34a (Agostini et al., 2011) and miR-34c (Zovoilis et al., 2011) , were subsequently shown to occur in Alzheimer disease (AD) . Studies demonstrated an increase in miR-34a expression in the brain cortices of AD mouse models (Wang et al., 2009; Agostini et al., 2011) , and a specific interaction between miR-34a, Tap73, and synaptotagmin-1. In the brains of patients with AD, the miR-34a, Tap73, and synaptotagmin-1 circuit is conserved despite aberrant expression of p73 (Agostini et al., 2011) . Tap73 is a p53-family member and drives the expression of miR-34a. Similar studies indicated that miR-34c levels were elevated in the hippocampus of patients with AD and in diseasemodeling mice, and inhibition of miR-34c improved memory function (Zovoilis et al., 2011; Hu et al., 2015) . Recently the activity of miR-34 in age-associated changes and long-term integrity has been positively associated with ageing and neurodegeneration in Drosophila (Liu et al., 2012) .
Thus far, the role of miR-34a in ICH has not been revealed. Whether its inhibition (by countersequenced miR-34a) would have a neuroprotective effect was thus studied using an in vitro ICH-induced thrombin toxicity model.
Materials and methods

A cortical primary culture
Cortical neurons obtained from cerebral cortices of 17-day-old rat embryos were cultured as described previously (Beaudoin et al., 2012) . Then 1 × 10 6 cells were seeded per well into a 12-well plate (1 mL/well) coated with glass coverslips. Cells were grown under standard conditions at 37 °C and 5% CO 2 in Neurobasal medium with B27 (Invitrogen, Carlsbad, CA, USA) and glutamine (Invitrogen).
In vitro thrombin toxicity model and therapeutic potential study
To simulate neuronal injury, a thrombin in vitro toxicity model was assembled by using thrombin (Sigma, NY, USA) to cortical neurons. Thrombin was used at constant concentration. Then the cell viability was assessed by the WST-1 cell proliferation assay kit (Roche, Penzberg, Germany), according to the manufacturer's instructions. After using diverse concentrations of thrombin, we observed that 200 U/mL thrombin administration resulted in 50% cell death and 500 U/mL thrombin administration resulted in 90% cell death after 24 h. Thus, 500 U/mL was chosen as the concentration for thrombin in all further experiments. The therapeutic potential of AM34a was studied from the thrombin in vitro injury model. The cells were transfected by AM34a (50 nM) with Lipofectamine 2000 (Invitrogen). Analyses were performed 48 h after transfection. 2.3. Quantitative real-time polymerase chain reaction miRNA was extracted using the mirVana miRNA isolation kit (Ambion, Austin, TX, USA), following the manufacturer's recommended protocol. Realtime polymerase chain reaction (PCR) for miRNA was performed using commercial kits (GenoSensor Corporation, Tempe, AZ, USA) and miRNA specific primer (GenoSensor Corporation). Relative expression was calculated from the formula: relative expression = 2 -△Ct using the comparative threshold cycle (Ct) and was normalized with the expression of control RNU6B (GenoSensor Corporation) from each sample. The sequences of miRNAs are as follows: miR-34a, 3'-UGUUGGUCGAUUCUGUGACGGU-5' . Antagonistic sequences (AM34a) of single stranded RNAs with cholesterol residue at the 3' ending and phosphorothioate backbone were manufactured to neutralize the targeted miRNAs (Bioneer, Daejon, Korea).
Cell proliferation and MTT assay
Cell survival analysis was conducted according to the MTT (Cell Titer 96 Aqueous Cell Proliferation Assay kit; Promega, Madison, WI, USA) assay method. The absorbance was assessed in a microplate reader at 490 nm, and the results were shown as a percentage of the control.
Immunocytochemistry and TUNEL assay
The terminal deoxynucleotidyl transferase mediated digoxigenin-dUTP-biotin nick-end labeling (TUNEL) assay using the In Situ Cell Death Detection Kit (Roche, Penzberg, Germany) was used to show apoptosis by demonstrating apoptotic bodies in primary cortical neurons. Apoptotic cells were determined with a model LSM 510 confocal microscope (Carl Zeiss, Jena, Germany). Data were expressed as the ratio of apoptotic neurons to total nuclei. Cell counting was performed by microscope in triplicate.
Western blot analysis
Cells were resuspended in a lysis buffer (Cell Signaling Technology, Beverly, MA, USA) with Protease Inhibitor Cocktail (complete mini tablet, Roche). The membranes were blocked by incubation for 1 h at room temperature and incubated with anti-BDNF (Santa Cruz, CA, USA), anti-cleaved caspase-3 (Cell Signaling Technology, MA, USA), anti-phospho-Akt (Cell Signaling Technology), anti-phospho-ERK (Cell Signaling Technology), and Actin (Cell Signaling Technology) antibodies at 4 °C overnight. After three washes, the membranes was further incubated with horseradish peroxidase-conjugated antisecondary IgG (Invitrogen) antibody and visualized with Chemiluminescent Substrate (Pierce, IL, USA). Densitometric quantification of the protein density bands was performed using the ImageJ software (version 1.29 x, NIH, Bethesda, MD, USA). Error bars denote the mean (±SD) of three replicates. 2.7. Statistical analyses Differences are described as average and standard deviation. When comparing means between two groups, Student's t test was used. P < 0.025 was considered the level of statistical significance.
Results
MicroRNA 34a expression profile in the ICHinduced thrombin injury model
To simulate injury after ICH, an in vitro thrombin toxicity model was constructed by applying thrombin to cortical neurons. The miRNA expression level was then evaluated in this model. Cortical neuronal cells were cultured in a neural medium and exposed to 500 U thrombin for 24 h. The level of miR-34a increased significantly 24 h after thrombin injury (*P < 0.05; Figure 1 ). We investigated miR-34a to validate the protective effect of its inhibitory sequence. The application of AM34a increased cell viability after the thrombin injury (Figure 2 ).
Apoptosis in the ICH-induced thrombin injury model after AM34a administration
TUNEL assays are a sensitive means of visualizing DNA damage in single cells; they are also useful for detecting cell death. Cultured cells were fixed and stained for TUNEL and 4' , 6-diamidino-2-phenylindole (DAPI) staining. Confocal microscopy was used to compare the model cells with and without AM34a. The apoptotic cells measured by TUNEL after thrombin injury were decreased by AM34a (*P < 0.025; Figure 3 ). The AM34a treatment also induced noticeable functional improvement. A secondary antibody was used to rule out nonspecific staining (data not shown).
Caspase-3 activation is the key event in apoptotic cell death. To evaluate the effects of AM34a on neuronal cell apoptosis, we determined the levels of activated caspase-3 in the thrombin injury model with and without AM34a treatment by western blot analysis. Cortical neuronal cells that had been cultured without AM34a showed an increase in the levels of caspase-3 compared to those cultured with AM34a (*P < 0.025; Figure 4) . 3.3. Effects of AM34a are mediated via activation of the BDNF-Akt pathway BDNF is one of the best characterized neurotrophic factors that are important in neuronal survival, differentiation, and synaptogenesis. To examine the protective effect of AM34a, we analyzed BDNF levels. The results from western blot analysis indicated that BDNF levels increased following exposure of a thrombin injury model to treatment with AM34a (*P < 0.025; Figure 5 ).
Akt phosphorylation inactivates apoptotic factors and ERK phosphorylation is activated by growth signals. To examine the underlying mechanisms of these processes, we analyzed a variety of signaling cascades involved in cell growth and survival. We performed western blot analyses for phosphorylated Akt (p-Akt) and phosphorylated ERK (p-ERK) and found that the levels of both were significantly higher in the thrombin injury model treated with AM34a (*P < 0.025; Figures 6 and 7) .
Discussion
In spite of outstanding progress in ischemic stroke treatment technology, little progress has been made in the treatment of ICH in the past 10 years. Several potential neuroprotective agents have failed to show positive outcomes, and current effective treatment options for ICH are still limited to supportive management (Qureshi et al., 2009; Levi et al., 2010) . The present study revealed the patterns of miRNA expression after ICH induction and its results indicate that upregulated miRNAs could be a potential therapeutic target in ICH. When miR-34a was abrogated by the application of its antagonist, neuronal survival was increased in the in vitro ICH thrombin toxicity model, apoptotic cell death was reduced, and functional improvement was facilitated. miR-34a regulates BDNF, and AM34a, the antagomir inhibiting miR-34a, enhances BDNF levels. These results represent the first evidence that miRNA-dependent dysregulation of BDNF participates in the pathogenesis of ICH and that AM34a may be therapeutically effective against this devastating disorder. Figure 1 . MicroRNA 34a expression in the ICH-induced thrombin injury model. Expression levels of miR-34a in the ICHinduced thrombin injury model were detected using quantitative polymerase chain reaction assay. Cortical neuronal cells were cultured in a neural medium and exposed to 500 U of thrombin for 24 h. The level of miR-34a increased significantly 24 h after thrombin injury. Values represent the mean ± standard deviation (SD) of three experiments, with n = 3 dishes/culture for each concentration. *P < 0.025 compared with nontreated groups. To examine the protective effect of AM34a, we analyzed BDNF levels. Thrombin was added to cells in the presence of AM34a, after which toxicity was estimated by western blotting. Results showed that BDNF levels increased following exposure of a thrombin injury model to treatment with AM34a. Values represent the mean ± standard deviation (SD) of three experiments, with n = 3 dishes/ culture for each concentration (*P < 0.025). Apoptosis appears to play a key role in the neural damage caused by stroke (Matsushita et al., 2000; Qureshi, 2003) . The induction of ICH in rats has been shown to induce neuronal cell death, and apoptosis has been closely linked to ICHinduced neuronal cell death (Matsushita et al., 2000) . The upregulation of caspase3 is an important indicator of apoptosis following brain insults (Benchoua et al., 2004 ). An increase in the number of TUNEL and caspase3positive cells in the hippocampus indicates an increase in apoptotic neuronal cell death in the hippocampus (Baek et al., 2012) . The proapoptotic molecule causes the death of nerve cells following cerebral ischemia by the release of cytochrome c and the activation of caspases (Plesnila et al., 2002) . Histological examination of the ICH-model cells revealed heavy staining on the TUNEL assay, with the cells demonstrating apoptotic morphological features. In the present study, we used a characterized ICH-induced thrombin toxicity model and we found that AM34a treatment resulted in a decreased level of cleaved caspase-3, suggesting that AM34a exerts an anti-apoptotic effect.
BDNF is a small dimeric protein that modulates neuronal cell growth and survival and has been implicated in learning and memory processes. Accordingly, dysfunction in BDNF is accompanied by cognitive deficits (GomezPinilla and Vaynman, 2005) . Specifically, BDNF enhances hippocampaldependent memory and a form of synaptic plasticity (Minichiello, 2009) , BDNF concentrations are high in the hippocampus, and its expression is selectively increased during learning and memory tasks (Zimmerberg et al., 2009 ). In the present study, the level of BDNF was decreased in the ICH-induced thrombin toxicity model. The reduced BDNF level is involved in the impairment induced by ICH-induced thrombin toxicity. By contrast, AM34a treatment led to increased levels of BDNF in the model. The results from the present study indicate that AM34a increased BDNF and ameliorated some of the negative effects of the toxicity in the model. The PI3K/Akt signaling pathway mediates mitogendependent growth and survival, and inhibition of this pathway results in apoptosis . Akt activity can be modulated by phosphorylation of either Thr308 or Ser47e (Koide et al., 2011) . Phosphorylation of Akt itself inactivates pro-apoptotic factors and inhibits apoptosis (Lubinus et al., 1994; Li et al., 2013) . Akt and ERK are known to inhibit apoptosis by inhibiting caspase activation. In the current study, we used a characterized cortical neuronal cell ICH thrombin toxicity model. Akt expression in this model was influenced by AM34a modulation, and the cell survival pathway activated by AM34a treatment is thus a reasonable potential therapeutic mechanism of AM34a. In addition, phosphorylation and activation of Akt may underlie the observed protective effect of BDNF. The neuroprotective effect of AM34a is probably mediated by BDNF pathway up-reregulation with decreased apoptotic cell death. In particular, the anti-apoptotic effect may result from the AM34a-mediated increase in the expression of BDNF via activation of the Akt and ERK pathways. Based on these results, AM34a may be a good candidate for exerting a neuroprotective effect and improving neuronal recovery following apoptosis.
Thrombin was applied on the cortical neuronal cells to mimic an in vitro ICH-induced toxicity condition, and it is obvious that more extensive mechanisms are related to posthemorrhagic neuronal damage (Qureshi et al., 2009 ). In the present study, we evaluated the protective effect of miR-34a as derived from this in vitro model. Further studies regarding manipulation of in vivo ICH models are necessary to confirm the benefit of the miRNA modulation strategy. In conclusion, we demonstrated a distinct miRNA expression pattern after an in vitro ICH injury and revealed that its modulation can have therapeutic potential. miR-34a antagomir reduced cell death and enhanced neurological recovery by activating the BDNF pro-survival pathway. This suggests that inhibiting miR34a might be of potential therapeutic use in ICH.
